COLLEGIUM PHARMACEUTICAL, INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2014 to Q2 2024.
  • Collegium Pharmaceutical, Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 32.4M shares, a 6.32% decline year-over-year.
  • Collegium Pharmaceutical, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 33.7M shares, a 0.26% decline from 2022.
  • Collegium Pharmaceutical, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 33.8M shares, a 3.17% decline from 2021.
  • Collegium Pharmaceutical, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 34.9M shares, a 1.54% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 32.4M -2.19M -6.32% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 32.3M -1.99M -5.81% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 32.3M -1.28M -3.81% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 33.7M -315K -0.92% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-22
Q2 2023 34.6M +621K +1.83% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 34.3M +645K +1.92% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 33.6M -541K -1.59% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 34.1M -1.32M -3.72% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 34M -1.3M -3.69% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 33.7M -1.28M -3.66% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 34.1M -469K -1.36% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 35.4M +834K +2.41% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 35.3M +907K +2.64% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 35M +851K +2.5% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 34.6M +1.14M +3.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 34.5M +1.06M +3.16% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 34.4M +998K +2.99% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 34.1M +769K +2.31% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 33.5M +204K +0.61% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 33.5M +470K +1.42% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 33.4M +430K +1.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 33.3M +428K +1.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 33.3M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 33M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 33M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 32.9M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q1 2016 23.1M +22.1M +2209% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-11
Q4 2015 20.6M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 20.5M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 11.8M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 1M +89.1K +9.76% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q1 2014 913K Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-07-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.